Mushroom supplement may slow prostate cancer progression, City of Hope study finds

City of Hope research showcases innovation at 2025 AACR annual meeting

City of Hope researchers at AACR.City of Hope presented more than 74 sessions at this year’s American Association for Cancer Research Annual Meeting in Chicago, highlighting breakthroughs in diagnostics, treatment options and AI-powered precision medicine.

City of Hope opens largest outpatient cancer center in its national system

City of Hope opened its largest outpatient facility among its network of 38 U.S. locations—Hope Plaza.

May 16, 2025

Vol.51 No.19

Clinical Roundup

Shorter radiation therapy after prostate surgery safe, UCLA study finds

For men who undergo a radical prostatectomy for the treatment of prostate cancer, post-surgery radiation therapy can play a vital role in reducing the risk of recurrence.

May 16, 2025

Vol.51 No.19

Clinical Roundup

New compound targets circadian clock machinery in cells to fight glioblastoma

A series of preclinical studies show that a new compound, SHP1705, targets circadian clock proteins hijacked by glioblastoma stem cells, impairing the cancer cells’ ability to survive and grow.

May 16, 2025

Vol.51 No.19

Rewriting the rules of cancer treatment one nanobody at a time

I joined Translational Genomics Research Institute, part of City of Hope, late last year to launch the Center for Accelerated Nanotherapeutics.

Durvalumab regimen demonstrates improvement in DFS for high-risk NMBIC in phase III trial

Positive high-level results from the POTOMAC phase III trial showed one year of treatment with Imfinzi (durvalumab) plus standard-of-care BCG induction and maintenance therapy demonstrated a statistically significant and clinically meaningful improvement in disease-free survival for patients with high-risk non-muscle-invasive bladder cancer compared to BCG induction and maintenance therapy alone.

May 09, 2025

Vol.51 No.18

Mushroom supplement may slow prostate cancer progression, City of Hope study finds

YOU MAY BE INTERESTED IN

City of Hope research showcases innovation at 2025 AACR annual meeting

City of Hope opens largest outpatient cancer center in its national system

Shorter radiation therapy after prostate surgery safe, UCLA study finds

New compound targets circadian clock machinery in cells to fight glioblastoma

Rewriting the rules of cancer treatment one nanobody at a time

Durvalumab regimen demonstrates improvement in DFS for high-risk NMBIC in phase III trial

Renew today!

Subscriber content

Never miss an issue!

Login